Cited by 1,028Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychoanalysis and Psychopathology Research

The DOI matches its Crossref record; 300 of the 302 references it cites were found in a registry or an index.

Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

Lorrin M. Koran, Gregory L. Hanna, Eric Hollander, Gerald Nestadt, Helen Blair Simpson·2008·APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches

DOI 10.1176/appi.books.9780890423363.149114

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1176/appi.books.9780890423363.149114

Cites

300 of 300 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Items 201–300 of 300

St John??s wort versus placebo in obsessive???compulsive disorder: results from a double-blind study
Kobak, K. A., Taylor, L. V. H., Bystritsky, A., Kohlenberg, C. J., Greist, J. H., Tucker, P. M., Warner, G., Futterer, R., & Vapnik, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200511000-00003 · Cited by 88
Olanzapine and the new generation of antipsychotic agents: patterns of use.
Flament, M. F., & Bisserbe, J. C. (1997) · PubMed · Cited by 87
Home self-assessment of obsessive-compulsive disorder: Use of a manual and a computer-conducted telephone interview: two UK-US studies
Marks, I. M., Baer, L., Greist, J. H., Park, J.-M., Bachofen, M., Nakagawa, A., Wenzel, K. W., Parkin, J. R., Manzo, P. S., Dottl, S. L., et al. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.5.406 · Cited by 86
Strategies for the treatment of antidepressant-related sexual dysfunction.
Zajecka, J. (2001) · PubMed · Cited by 86
Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder
Stewart, S. E., Stack, D. E., Farrell, C., Pauls, D. L., & Jenike, M. A. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.01.004 · Cited by 86
Risperidone-Induced Obsessive-Compulsive Symptoms: A Series of Six Cases
Alevizos, B., Lykouras, L., Zervas, I. M., & Christodoulou, G. N. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00004 · Cited by 84
Combination Treatment with Clomipramine and Selective Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Children and Adolescents
FIGUEROA, Y., ROSENBERG, D. R., Birmaher, B. B., & Keshavan, M. S. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.61 · Cited by 82
Suicidal Risk in Antidepressant Drug Trials
Baldessarini, R. J., Pompili, M., & Tondo, L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.246 · Cited by 80
Weight Gain During Long-Term Treatment of Obsessive-Compulsive Disorder: A Prospective Comparison Between Serotonin Reuptake Inhibitors
Maina, G., Albert, U., Salvi, V., & Bogetto, F. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1011 · Cited by 79
Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79
Late-Onset Obsessive-Compulsive Disorder
Weiss, A. P., & Jenike, M. A. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.2.265 · Cited by 78
The Treatment of Severe, Chronic, Resistant Obsessive-Compulsive Disorder
Drummond, L. M. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.223 · Cited by 76
Obsessive–compulsive symptoms in patients with temporal lobe epilepsy
Isaacs, K. L., Philbeck, J. W., Barr, W., Devinsky, O., & Alper, K. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.04.009 · Cited by 76
Outcome predictors for severe obsessive–compulsive patients in intensive residential treatment
Stewart, S. E., Yen, C.-H., Stack, D. E., & Jenike, M. A. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.08.007 · Cited by 75
A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction
DeBattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Loraas, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0706 · Cited by 75
Selecting national items for the WHOQOL: conceptual and psychometric considerations
Skevington, S. M., Bradshaw, J., & Saxena, S. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00355-4 · Cited by 74
Family approaches to treatment for obsessive compulsive disorder
Steketee, G. S., & Noppen, B. L. V. (2003) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462003000100009 · Cited by 73
Behavior therapy augments response of patients with obsessive–compulsive disorder responding to drug treatment
Tenneij, N. H., van Megen, H. J. G. M., Denys, D. A. J. P., & Westenberg, H. G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0913 · Cited by 71
The Shyness and Social Anxiety Workbook
Antony, M. M., & Swinson, R. P. (2000) · New Harbinger Publications eBooks · Cited by 71
Treatment of compulsive hoarding
Saxena, S., & Maidment, K. M. (2004) · Journal of Clinical Psychology · doi:10.1002/jclp.20079 · Cited by 70
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy
Nordeng, H., & Spigset, O. (2005) · Drug Safety · doi:10.2165/00002018-200528070-00002 · Cited by 70
Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder
Stein, D. J., Montgomery, S., Kasper, S. F., & Tanghøj, P. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00007 · Cited by 70
Selective serotonin reuptake inhibitor discontinuation syndrome: A review
Tamam, L., & Özpoyraz, N. (2002) · Advances in Therapy · doi:10.1007/bf02850015 · Cited by 69
Refractory obsessive compulsive disorder and ECT.
Maletzky, B. M., McFarland, B., & Burt, A. (1994) · PubMed · Cited by 69
Clonidine treatment of excessive sweating.
Feder, R. (1995) · PubMed · Cited by 69
A score for predicting response to pharmacotherapy in obsessive???compulsive disorder
Denys, D., Burger, H., van Megen, H., de Geus, F., & Westenberg, H. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200311000-00002 · Cited by 68
Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
Szegedi, A., Wetzel, H., Leal, M., Härtter, S., & Hiemke, C. (1996) · PubMed · Cited by 67
Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two–year follow–up
Kordon, A., Kahl, K. G., Broocks, A., Voderholzer, U., Rasche-Räuchle, H., & Hohagen, F. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0533-y · Cited by 66
Citalopram for treatment-resistant obsessive-compulsive disorder
Pallanti, S., Quercioli, L., Paiva, R. S., & Koran, L. M. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80725-1 · Cited by 66
Self-citation
Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder
Lepola, U. M., Bergtholdt, B., Lambert, J. S., Davy, K., & Ruggiero, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0213 · Cited by 66
Clinical Characteristics of Response to Fluoxetine Treatment of Obsessive-Compulsive Disorder
Ackerman, D. L., Greenland, S., & Bystritsky, A. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00002 · Cited by 65
Do personality disorders predict negative treatment outcome in obsessive–compulsive disorders? A prospective 6-month follow-up study
Fricke, S., Moritz, S., Andresen, B., Jacobsen, D., Kloss, M., Rufer, M., & Hand, I. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.03.010 · Cited by 64
Antipsychotic augmentation for treatment resistant obsessive???compulsive disorder: what if antipsychotic is discontinued?
Maina, G., Albert, U., Ziero, S., & Bogetto, F. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000047784.24295.2b · Cited by 61
The Serotonin Syndrome
Keck, P. E., & Arnold, L. M. (2000) · Psychiatric Annals · doi:10.3928/0048-5713-20000501-11 · Cited by 61
Personality disorders do not influence the results of cognitive and behavior therapy for obsessive compulsive disorder
Dreessen, L., Hoekstra, R. J., & Arntz, A. R. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00027-3 · Cited by 60
Combining Pharmacotherapy with Cognitive‐Behavioral Interventions for Obsessive‐Compulsive Disorder
Cottraux, J., Bouvard, M. A., & Milliery, M. (2005) · Cognitive Behaviour Therapy · doi:10.1080/16506070510043750 · Cited by 60
Antidepressant-Induced Sweating
Marcy, T. R., & Britton, M. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e564 · Cited by 59
Cognitive-Behavioral Treatment for Panic Disorder: Current Status
Landon, T. M., & Barlow, D. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200407000-00002 · Cited by 59
Suicide and self‐harm following prescription of SSRIs and other antidepressants: confounding by indication
Didham, R. C., McConnell, D. W., Blair, H. J., & Reith, D. M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02480.x · Cited by 59
How to treat OCD in patients with Tourette syndrome
Miguel, E. C., Shavitt, R. G., Ferrão, Y. A., Brotto, S. A., & Diniz, J. B. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00583-4 · Cited by 59
The Hair-Pulling Problem: A Complete Guide to Trichotillomania
Penzel, F. (2003) · Cited by 58
Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
Tollefson, G. D., Birkett, M. A., Koran, L. M., & Genduso, L. A. (1994) · PubMed · Cited by 57
Self-citation
Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
Koran, L. M., Jw, C., Ra, D., Rush, A. J., & Thiemann, S. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.11.1450 · Cited by 56
Self-citation
Obsessive-Compulsive and Related Disorders in Adults: A Comprehensive Clinical Guide
Koran, L. M. (1999) · Cited by 53
Self-citation
Clinical Neuroimaging in Psychiatry
Rauch, S. L., & Renshaw, P. F. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017151 · Cited by 52
Standard criteria for relapse are needed in obsessive-compulsive disorder
Simpson, H. B., Franklin, M. E., Cheng, J., Foa, E. B., & Liebowitz, M. R. (2005) · Depression and Anxiety · doi:10.1002/da.20052 · Cited by 50
Self-citation
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.
Goodman, W. K., Ward, H. E., Kablinger, A. S., & Murphy, T. K. (1997) · PubMed · Cited by 50
Pharmacotherapy for major depression in children and adolescents
Wagner, K. D. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.005 · Cited by 49
Concise Guide to Drug Interaction Principles for Medical Practice: Cytochrome P450s, Ugts, P-Glycoproteins
Cozza, K. L., Armstrong, S. C., & Oesterheld, J. R. (2003) · Cited by 49
Long-Term Efficacy of Exposure and Ritual Prevention Therapy and Serotonergic Medications for Obsessive-Compulsive Disorder
Hembree, E. A., Riggs, D. S., Kozak, M. J., Franklin, M. E., & Foa, E. B. (2003) · CNS Spectrums · doi:10.1017/s1092852900018629 · Cited by 48
Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions
Stein, D. J., Kasper, S. F., Andersen, E. W., Nil, R., & LADER, M. H. (2004) · Depression and Anxiety · doi:10.1002/da.20043 · Cited by 47
Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors
Bogan, A. M., Koran, L. M., Chuong, H. W., Vapnik, T., & Bystritsky, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0110 · Cited by 47
Self-citation
Assessment of DSM-IV Personality Disorders in Obsessive-Compulsive Disorder: Comparison of Clinical Diagnosis, Self-Report Questionnaire, and Semi-Structured Interview
Tenney, N. H., Schotte, C., Denys, D. A. J. P., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.6.550.25352 · Cited by 47
Acute Psychostimulant Challenge in Primary Obsessive-Compulsive Disorder
JOFFE, R. T., SWINSON, R. P., & LEVITT, A. J. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199108000-00003 · Cited by 46
Efficacy of sildenafil citrate (Viagra®) for the treatment of erectile dysfunction in men in remission from depression
Tignol, J., Furlan, P. M., Gómez-Beneyto, M., Opsomer, R. J., Schreiber, W., Sweeney, M., & Wohlhuter, C. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000117902.43995.b0 · Cited by 45
Pulse-Loaded Intravenous Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder
Koran, L. M., Aboujaoude, E. N., Ward, H. E., Shapira, N. A., Sallee, F. R., Gamel, N. N., & Elliott, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195112.24769.b3 · Cited by 44
Self-citation
Cognitive therapy of obsessive thoughts
Freeston, M. H., Léger, É., & Ladouceur, R. (2001) · Cognitive and Behavioral Practice · doi:10.1016/s1077-7229(01)80045-6 · Cited by 43
Current approaches to management of depression in Parkinson’s Disease
Vajda, F. J. E., & Solinas, C. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.03.008 · Cited by 43
Compulsive personality as predictor of response to serotoninergic antidepressants.
Ansseau, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (1991) · BMJ · doi:10.1136/bmj.303.6805.760 · Cited by 42
Prevalence and symptomatology of comorbid obsessive–compulsive disorder among bulimic patients
Matsunaga, H., Kiriike, N., Miyata, A., Iwasaki, Y., Matsui, T., Fujimoto, K., Kasai, S., Kaye, W. H., & Kaye, W. H. (1999) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1999.00622.x · Cited by 42
Overcoming Shyness and Social Phobia: A Step-by-Step Guide
Rapee, R. M. (1998) · Medical Entomology and Zoology · Cited by 42
Nicotine treatment of obsessive–compulsive disorder
Lundberg, S., Carlsson, A., Norfeldt, P., & Carlsson, M. L. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.014 · Cited by 40
Worldwide use of clomipramine.
Trimble, M. (1990) · PubMed · Cited by 39
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Fochtmann, L. J., & Gelenberg, A. J. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.1.34 · Cited by 38
Cognitive behavioral therapy for obsessive-compulsive disorder: An update
Huppert, J. D., & Franklin, M. E. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0080-x · Cited by 37
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
Carrasco, J. L., Hollander, E., Schneier, F. R., & Liebowitz, M. R. (1992) · PubMed · Cited by 36
Self-citation
Topics in migraine management
Evans, R. W., & Lipton, R. B. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70003-7 · Cited by 36
Emergence of Symptoms of Tourette's Syndrome during Fluvoxamine Treatment of Obsessive–Compulsive Disorder
Fennig, S., Fennig, S., Pato, M. T., & Weitzman, A. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.6.839 · Cited by 35
Cyproheptadine for Drug-Induced Sweating
Ashton, A. K., & Weinstein, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.874-a · Cited by 35
Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.
Bies, R. R., Bigos, K. L., & Pollock, B. G. (2003) · PubMed · Cited by 33
High-Dose Sildenafil Citrate for Selective Serotonin Reuptake Inhibitor–Associated Ejaculatory Delay
Seidman, S. N., Pesce, V., & Roose, S. P. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0616 · Cited by 33
The Paradox of Quetiapine in Obsessive-Compulsive Disorder
Tranulis, C., Potvin, S., Gourgue, M., Leblanc, G., Mancini-Marı̈e, A., & Stip, É. (2005) · CNS Spectrums · doi:10.1017/s1092852900022719 · Cited by 31
Obsessive-compulsive disorder and borderline personality disorder
Hermesh, H., Shahar, A., & Munitz, H. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.1.120b · Cited by 31
Benztropine for Venlafaxine-Induced Night Sweats
Pierre, J. M., & Guzé, B. H. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00025 · Cited by 30
A preliminary study of partial hospital management of severe obsessive- compulsive disorder
Bystritsky, A., Munford, P. R., Rosen, R. M., Martin, K. M., Vapnik, T., Gorbis, E., & Wolson, R. C. (1996) · Psychiatric Services · doi:10.1176/ps.47.2.170 · Cited by 29
Obsessive–compulsive symptoms with olanzapine
Alevizos, B., Papageorgiou, C., & Christodoulou, G. N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004456 · Cited by 28
Evaluating Treatment Methods for Depressive Disorders
Zung, W. W. K. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.124.11s.40 · Cited by 28
Management of Obsessive-Compulsive Rituals Associated with Delusions, Hallucinations and Depression: A Case Report
Lelliott, P. T., & Marks, I. M. (1987) · Behavioural Psychotherapy · doi:10.1017/s0141347300010648 · Cited by 26
Inpatient Treatment of Patients With Severe Obsessive-Compulsive Disorder
Calvocoressi, L., McDougle, C. J., Wasylink, S., Goodman, W. K., Trufan, S. J., & Price, L. H. (1993) · Psychiatric Services · doi:10.1176/ps.44.12.1150 · Cited by 26
Chronic pain and posttraumatic stress disorder
Rapaport, M. H. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.1.120a · Cited by 25
Cognitive-Behavioral Therapy for Social Anxiety Disorder: Supporting Evidence and Future Directions
Hambrick, J. P., Weeks, J. W., Harb, G. C., & Heimberg, R. G. (2003) · CNS Spectrums · doi:10.1017/s1092852900018630 · Cited by 21
Mirtazapine in drug-induced excessive sweating
Buecking, A., Vandeleur, C. L., Khazaal, Y., & ZULLINO, D. F. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0956-z · Cited by 21
Clomipramine-Induced Tourettism in Obsessive-Compulsive Disorder
Kotler, M., Iancu, I., Kindler, S., Lefkifker, E., & Zohar, J. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199408000-00005 · Cited by 21
Triumph over shyness : conquering shyness and social anxiety
Stein, M. B., & Walker, J. R. (2002) · McGraw-Hill eBooks · Cited by 19
Evaluation of a naturalistic maintenance program in the treatment of obsessive-compulsive disorder: A preliminary investigation
McKay, D., Todaro, J. F., Neziroglu, F. A., & Yaryura-Tobias, J. A. (1996) · Journal of Anxiety Disorders · doi:10.1016/0887-6185(96)00006-0 · Cited by 18
Overcoming Social Anxiety and Shyness: A Self-Help Guide Using Cognitive Behavioral Techniques
Butler, G., & DOBSON, D. J. G. (2001) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.15.4.381 · Cited by 17
Parents' Education as Autism Therapists: Applied Behaviour Analysis in Context
Keenan, M., Kerr, K. P., & Dillenburger, K. (1999) · Cited by 16
Psychopharmacology of comorbid obsessive-compulsive disorder and depression.
den Boer, J. A. (1997) · PubMed · Cited by 16
Parents' Education as Autism Therapists: Applied Behaviour Analysis in Context. By M. Keenan, K. Kerr & K. Dillenburger. Jessica Kingsley Publishers, London. pp. 175. £13.95 (pb).
Jordan, R. R. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1017/s0021963001216795 · Cited by 14
Comorbid Obsessive-Compulsive Disorder and Tourette Syndrome
Eapen, V., & Robertson, M. M. (2000) · CNS Drugs · doi:10.2165/00023210-200013030-00004 · Cited by 13
Asperger syndrome : a guide for professionals and families
Ducharme, R., Gullotta, T. P., & Ramos, J. M. (2003) · doi:10.1007/978-1-4419-8883-6 · Cited by 12
Three Treatment Approaches for Obsessions
Neziroglu, F. A., & Neuman, J. (1990) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.4.4.377 · Cited by 12
Flying Without Fear
Brown, D., & Leahy, R. L. (1999) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.13.4.395 · Cited by 10
Current status of deep brain stimulation
Greenberg, B. D., Nahas, Z. H., & Carpenter, L. L. (2005) · Primary psychiatry · Cited by 9
The Agoraphobia Workbook: A Comprehensive Program to End Your Fear of Symptom Attacks
Pollard, C. A., & Zuercher-White, E. (2003) · Cited by 6
Obsessive-Compulsive Personality Disorder
Sperry, L. (2010) · Taylor & Francis eBooks · doi:10.4324/9780203427088_chapter_8 · Cited by 6
Previous SRI treatment and efficacy of sertraline for OCD: Combined analysis of 4 multicenter trials
Rasmussen, S., Baer, L., & Shera, D. M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)86963-6 · Cited by 5
Convergent and divergent validity of the Beck Anxiety Inventory for patients with panic disorder and agoraphobia
de Beurs, E., Wilson, K. A., Chambless, D. L., Goldstein, A. J., & Feske, U. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:4
The broad autism phenotype: A complementary strategy for molecular genetic studies of autism
(2001) · doi:10.1002/1096-8628(20010108)105:1
Untitled work
(1996) · doi:10.1002/(sici)1520-6394(1996)4:3
Self-citation

Sorted by citations

Depression in Older Adults
Fiske, A., Wetherell, J. L., & Gatz, M. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153621 · Cited by 2,353
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Clinical experience suggests that some patients may benefit from adjunctive clomipramine; however, plasma levels should be monitored because of the risk of drug interactions with SSRIs [747,813].”
BackgroundInfluential
Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003
Obsessive-compulsive disorder
Abramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002

See all 1,028

Authors: Koran, L. M., Hanna, G. L., Hollander, E., Nestadt, G., & Simpson, H. B.
ORCID: Lorrin M. Koran
Gregory L. Hanna
Eric Hollander
Gerald Nestadt
Helen Blair Simpson
Venue: APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches
Publisher: American Psychiatric Association
Published: 2008-01-17
Volume: 164
Issue: 12 Suppl
Pages: 5-53
DOI: 10.1176/appi.books.9780890423363.149114
OpenAlex: W306343222
Cited by: 1,028
References: 302
Citations by year: 2026: 1 · 2025: 36 · 2024: 52 · 2023: 54 · 2022: 53 · 2021: 73 · 2020: 50 · 2019: 57 · 2018: 52 · 2017: 57 · 2016: 67 · 2015: 79 · 2014: 76 · 2013: 70 · 2012: 66
FWCI: 265.99
Type: book chapter
Language: en
Open access: closed
Locations: American Psychiatric Association Publishing eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords: obsessive-compulsive disorder, treatment, psychotherapy, pharmacotherapy, cognitive behavioral therapy, selective serotonin reuptake inhibitors
MeSH terms: Adolescent, Adult, Age Factors, Child, Combined Modality Therapy, Female, Humans, Male, Obsessive-Compulsive Disorder, Patient Care Planning, Patient Compliance, Pregnancy, Psychiatric Status Rating Scales, Psychotherapy, Severity of Illness Index, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks